Małgorzata Bajor

914 total citations
19 papers, 626 citations indexed

About

Małgorzata Bajor is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Małgorzata Bajor has authored 19 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Immunology. Recurrent topics in Małgorzata Bajor's work include Redox biology and oxidative stress (6 papers), CAR-T cell therapy research (4 papers) and Immune Cell Function and Interaction (4 papers). Małgorzata Bajor is often cited by papers focused on Redox biology and oxidative stress (6 papers), CAR-T cell therapy research (4 papers) and Immune Cell Function and Interaction (4 papers). Małgorzata Bajor collaborates with scholars based in Poland, Norway and United States. Małgorzata Bajor's co-authors include Radosław Zagożdżon, Agnieszka Graczyk‐Jarzynka, Leszek Kaczmarek, Zofia Pilch, Małgorzata Firczuk, Magdalena Winiarska, Marta Siernicka, Angelika Muchowicz, Grzegorz Wiera and Jerzy W. Mozrzymas and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Małgorzata Bajor

19 papers receiving 621 citations

Peers

Małgorzata Bajor

ONCOL

IMMUN

CMN

Kelly A. Martin United States

Linda Henneman Netherlands

Christina Mølck Australia

Gabriel L. Fiszman Argentina

Susanne Feldhaus Germany

Luca Simula France

Aline Appert-Collin France

María A. Jasnis Argentina

Çiğdem Selli Türkiye

Vivian Rodriguez‐Cruz United States

Kelly A. Martin United States

Małgorzata Bajor

408 ×1.6

241 ×0.9

ONCOL

110 ×0.5

IMMUN

133 ×1.7

40 ×0.7

CMN

Citations per year, relative to Małgorzata Bajor Małgorzata Bajor (= 1×) peers Kelly A. Martin

Countries citing papers authored by Małgorzata Bajor

Since Specialization

Citations

This map shows the geographic impact of Małgorzata Bajor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Małgorzata Bajor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Małgorzata Bajor more than expected).

Fields of papers citing papers by Małgorzata Bajor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Małgorzata Bajor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Małgorzata Bajor. The network helps show where Małgorzata Bajor may publish in the future.

Co-authorship network of co-authors of Małgorzata Bajor

This figure shows the co-authorship network connecting the top 25 collaborators of Małgorzata Bajor. A scholar is included among the top collaborators of Małgorzata Bajor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Małgorzata Bajor. Małgorzata Bajor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Hajduk, Stephen L., Michał Łaźniewski, Agnieszka Graczyk‐Jarzynka, et al.. (2025). GPX4 is a key ferroptosis regulator orchestrating T cells and CAR-T-cells sensitivity to ferroptosis. Cancer Immunology Immunotherapy. 74(9). 280–280. 4 indexed citations

Madzio, Joanna, Agata Pastorczak, Martyna Poprzeczko, et al.. (2024). Concomitant inhibition of the thioredoxin system and nonhomologous DNA repair potently sensitizes Philadelphia‐positive lymphoid leukemia to tyrosine kinase inhibitors. HemaSphere. 8(3). e56–e56. 1 indexed citations

Bajor, Małgorzata, Agnieszka Graczyk‐Jarzynka, Anna Burdzińska, et al.. (2022). PD-L1 CAR effector cells induce self-amplifying cytotoxic effects against target cells. Journal for ImmunoTherapy of Cancer. 10(1). e002500–e002500. 43 indexed citations

Graczyk‐Jarzynka, Agnieszka, et al.. (2021). The Immune Landscape of Breast Cancer: Strategies for Overcoming Immunotherapy Resistance. Cancers. 13(23). 6012–6012. 33 indexed citations

Bajor, Małgorzata, Agnieszka Graczyk‐Jarzynka, Małgorzata Kurkowiak, et al.. (2020). Triple Combination of Ascorbate, Menadione and the Inhibition of Peroxiredoxin-1 Produces Synergistic Cytotoxic Effects in Triple-Negative Breast Cancer Cells. Antioxidants. 9(4). 320–320. 24 indexed citations

Firczuk, Małgorzata, et al.. (2019). Harnessing altered oxidative metabolism in cancer by augmented prooxidant therapy. Cancer Letters. 471. 1–11. 35 indexed citations

Pilch, Zofia, et al.. (2019). Targeting Negative and Positive Immune Checkpoints with Monoclonal Antibodies in Therapy of Cancer. Cancers. 11(11). 1756–1756. 113 indexed citations

Oei, Vincent Yi Sheng, Marta Siernicka, Agnieszka Graczyk‐Jarzynka, et al.. (2018). Intrinsic Functional Potential of NK-Cell Subsets Constrains Retargeting Driven by Chimeric Antigen Receptors. Cancer Immunology Research. 6(4). 467–480. 91 indexed citations

Bajor, Małgorzata, Agnieszka Graczyk‐Jarzynka, Angelika Muchowicz, et al.. (2018). Targeting peroxiredoxin 1 impairs growth of breast cancer cells and potently sensitises these cells to prooxidant agents. British Journal of Cancer. 119(7). 873–884. 54 indexed citations

10.

Bajor, Małgorzata, et al.. (2018). Application of Genome Editing Techniques in Immunology. Archivum Immunologiae et Therapiae Experimentalis. 66(4). 289–298. 16 indexed citations

11.

Bajor, Małgorzata, et al.. (2016). An Interplay of S-Nitrosylation and Metal Ion Binding for Astrocytic S100B Protein. PLoS ONE. 11(5). e0154822–e0154822. 17 indexed citations

12.

Kłossowski, Szymon, Małgorzata Bajor, Radosław Zagożdżon, et al.. (2015). Dimeric peroxiredoxins are druggable targets in human Burkitt lymphoma. Oncotarget. 7(2). 1717–1731. 40 indexed citations

13.

Bajor, Małgorzata, et al.. (2015). Abstract P5-07-09: Adenanthin, a new peroxiredoxin inhibitor, induces a switch between estrogen receptor alpha-mediated and Src/Akt-driven signaling in breast cancer cells. Cancer Research. 75(9_Supplement). P5–7. 2 indexed citations

14.

Siernicka, Marta, Magdalena Winiarska, Małgorzata Bajor, et al.. (2015). Adenanthin, a new inhibitor of thiol‐dependent antioxidant enzymes, impairs the effector functions of human natural killer cells. Immunology. 146(1). 173–183. 16 indexed citations

15.

Mucha, Krzysztof, Magdalena Bakun, Radosław Jaźwiec, et al.. (2014). Complement components, proteolysis‑related, and cell communication‑related proteins detected in urine proteomics are associated with IgA nephropathy. Polskie Archiwum Medycyny Wewnętrznej. 124(7-8). 380–386. 23 indexed citations

16.

Firczuk, Małgorzata, Małgorzata Bajor, Angelika Muchowicz, et al.. (2014). Peroxiredoxins-1 and 2 Affect Proliferation and Survival of Lymphoma Cells. Blood. 124(21). 1693–1693. 1 indexed citations

17.

Wiera, Grzegorz, et al.. (2013). Maintenance of long‐term potentiation in hippocampal mossy fiber—CA3 pathway requires fine‐tuned MMP‐9 proteolytic activity. Hippocampus. 23(6). 529–543. 48 indexed citations

18.

Bajor, Małgorzata & Leszek Kaczmarek. (2012). Proteolytic Remodeling of the Synaptic Cell Adhesion Molecules (CAMs) by Metzincins in Synaptic Plasticity. Neurochemical Research. 38(6). 1113–1121. 30 indexed citations

19.

Bajor, Małgorzata, Piotr Michaluk, Péter Gulyássy, et al.. (2012). Synaptic cell adhesion molecule‐2 and collapsin response mediator protein‐2 are novel members of the matrix metalloproteinase‐9 degradome. Journal of Neurochemistry. 122(4). 775–788. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact